Ferous, S.; Anastassopoulou, C.; Pitiriga, V.; Vrioni, G.; Tsakris, A.
Antimicrobial and Diagnostic Stewardship of the Novel β-Lactam/β-Lactamase Inhibitors for Infections Due to Carbapenem-Resistant Enterobacterales Species and Pseudomonas aeruginosa. Antibiotics 2024, 13, 285.
https://doi.org/10.3390/antibiotics13030285
AMA Style
Ferous S, Anastassopoulou C, Pitiriga V, Vrioni G, Tsakris A.
Antimicrobial and Diagnostic Stewardship of the Novel β-Lactam/β-Lactamase Inhibitors for Infections Due to Carbapenem-Resistant Enterobacterales Species and Pseudomonas aeruginosa. Antibiotics. 2024; 13(3):285.
https://doi.org/10.3390/antibiotics13030285
Chicago/Turabian Style
Ferous, Stefanos, Cleo Anastassopoulou, Vassiliki Pitiriga, Georgia Vrioni, and Athanasios Tsakris.
2024. "Antimicrobial and Diagnostic Stewardship of the Novel β-Lactam/β-Lactamase Inhibitors for Infections Due to Carbapenem-Resistant Enterobacterales Species and Pseudomonas aeruginosa" Antibiotics 13, no. 3: 285.
https://doi.org/10.3390/antibiotics13030285
APA Style
Ferous, S., Anastassopoulou, C., Pitiriga, V., Vrioni, G., & Tsakris, A.
(2024). Antimicrobial and Diagnostic Stewardship of the Novel β-Lactam/β-Lactamase Inhibitors for Infections Due to Carbapenem-Resistant Enterobacterales Species and Pseudomonas aeruginosa. Antibiotics, 13(3), 285.
https://doi.org/10.3390/antibiotics13030285
